Board of Directors
CHAIRDr Damian O’Connell Vice President of Clinical Research and Development, Pfizer |
 |
|
DIRECTORSProfessor Bill Powderly Head of the School of Medicine & Medical Science and Professor of Medicine & Therapeutics at University College Dublin and the Mater Misericordiae University Hospital |
 |
|
|
Professor Dermot Kelleher Vice-Provost for Medical Affairs, Professor of Clinical Medicine, Head of School of Medicine and Director of the Institute of Molecular Medicine at Trinity COllege Dublin and St James’s Hospital |
 |
|
|
Professor Des Fitzgerald Professor of Molecular Medicine and Vice-President for Research, University College Dublin |
 |
|
|
Professor Tim O' Brien Professor of Medicine and Director of the Regenerative Medical Institute, NUI Galway |
 |
|
|
Professor Larry Egan Chair of Clinical Pharmacology and Head of the Department of Pharmacology and Therapeutics, NUI Galway |
 |
|
|
Professor David Kerins Head of School of Medicine, University College Cork |
 |
|
|
Dr Willard Dere Senior Vice-President and International Chief Medical Officer of Amgen |
 |
|
|
Dr David Lloyd Head of the Molecular Design Group, School of Biochemistry & Immunology and Dean of Research, Trinity College Dublin |
 |
|
|
Professor Gerry McElvaney Professor of Medicine, Royal College of Surgeons in Ireland |
 |
|
|
Professor Hannah Mc Gee Dean of Faculty of Medical and Health Sciences and Professor of Psychology, Royal College of Surgeons in Ireland |
 |
|
|
Ms Helen Ryan Chief Executive, Creganna |
 |
|
|
Mr David Shanahan Global Head of Life Science, IDA |
.jpg) |
|
|
Dr Marina Zvartau-Hind Director, Neurosciences Medicines Development Centre and Clinical Leader of Alzheimer Disease Projects, GlaxoSmithKline |
 |
|
|
Mr John Coman Company Secretary for MMI and Corporate and Legal Affairs Secretary at University College Dublin |
 |
